1202 related articles for article (PubMed ID: 28662828)
1. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Liu J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.
Benjamin MM; Khalil RA
Exp Suppl; 2012; 103():209-79. PubMed ID: 22642194
[TBL] [Abstract][Full Text] [Related]
3. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
Wang X; Khalil RA
Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
Raffetto JD; Khalil RA
Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and Biological Attributes of Matrix Metalloproteinases.
Cui N; Hu M; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase inhibitors.
Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
[TBL] [Abstract][Full Text] [Related]
7. Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Metabolism: Insights into Health and Disease.
Molière S; Jaulin A; Tomasetto CL; Dali-Youcef N
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445827
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
[TBL] [Abstract][Full Text] [Related]
10. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
Kim IS; Yang WS; Kim CH
Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
[TBL] [Abstract][Full Text] [Related]
11. Zymography as a Research Tool in the Study of Matrix Metalloproteinase Inhibitors.
Ren Z; Chen J; Khalil RA
Methods Mol Biol; 2017; 1626():79-102. PubMed ID: 28608202
[TBL] [Abstract][Full Text] [Related]
12. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
13. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.
Reynolds JJ
Oral Dis; 1996 Mar; 2(1):70-6. PubMed ID: 8957940
[TBL] [Abstract][Full Text] [Related]
14. Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013-2023).
Almutairi S; Kalloush HM; Manoon NA; Bardaweel SK
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513440
[TBL] [Abstract][Full Text] [Related]
15. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
Chen Y; Peng W; Raffetto JD; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
[TBL] [Abstract][Full Text] [Related]
16. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
Fink K; Boratyński J
Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
[TBL] [Abstract][Full Text] [Related]
17. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.
Cabral-Pacheco GA; Garza-Veloz I; Castruita-De la Rosa C; Ramirez-Acuña JM; Perez-Romero BA; Guerrero-Rodriguez JF; Martinez-Avila N; Martinez-Fierro ML
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419373
[TBL] [Abstract][Full Text] [Related]
18. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
Haeusler G; Walter I; Helmreich M; Egerbacher M
Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
[TBL] [Abstract][Full Text] [Related]
19. Endogenous and synthetic MMP inhibitors in CNS physiopathology.
Baranger K; Rivera S; Liechti FD; Grandgirard D; Bigas J; Seco J; Tarrago T; Leib SL; Khrestchatisky M
Prog Brain Res; 2014; 214():313-51. PubMed ID: 25410364
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase inhibitors reduce collagen gel contraction and alpha-smooth muscle actin expression by periodontal ligament cells.
Bildt MM; Bloemen M; Kuijpers-Jagtman AM; Von den Hoff JW
J Periodontal Res; 2009 Apr; 44(2):266-74. PubMed ID: 18973523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]